Use of medication for attention-deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders

被引:18
|
作者
Ghirardi, Laura [1 ]
Chen, Qi [1 ]
Chang, Zheng [1 ]
Kuja-Halkola, Ralf [1 ]
Skoglund, Charlotte [2 ]
Quinn, Patrick D. [3 ]
D'Onofrio, Brian M. [1 ,4 ]
Larsson, Henrik [1 ,5 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Nobels Vag 12A, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[3] Indiana Univ, Dept Appl Hlth Sci, Sch Publ Hlth, Bloomington, IN 47405 USA
[4] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA
[5] Orebro Univ, Sch Med Sci, Orebro, Sweden
基金
瑞典研究理事会; 美国国家卫生研究院;
关键词
ADHD medication; injuries; neurodevelopmental disorders; DEFICIT-HYPERACTIVITY DISORDER; ADHD MEDICATION; YOUNG-PEOPLE; METHYLPHENIDATE; METAANALYSIS; ATOMOXETINE; POPULATION; PREVALENCE; SYMPTOMS; REGISTER;
D O I
10.1111/jcpp.13136
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Background Attention-deficit/hyperactivity disorder (ADHD) is often associated with other neurodevelopmental disorders (NDs) and with risky behaviors and adverse health outcomes, including injuries. Treatment with ADHD medication has been associated with reduced risk of injuries. However, it is unknown whether the association is present in individuals with co-occurring NDs. The aim of the present study was to estimate the association between ADHD medication use and unintentional injuries in Sweden in children and adolescents with ADHD, including those with co-occurring NDs. Methods Using a linkage of several national registers via the unique personal identification number, we identified individuals with a diagnosis of ADHD and of other NDs, including autism spectrum disorder, intellectual disability, communication disorders, learning disorders and motor disorders. The primary outcome was unintentional injuries. Secondary outcome was traumatic brain injury (TBI). Individuals were followed from January 1st 2006 or their 5th birthday or the date of the first unintentional injury, whichever came last, to December 31st 2013 or their 18th birthday or death, whichever came first. We compared the rate of injuries during periods on-treatment with the rate of injuries during periods off-treatment within the same individual using stratified Cox regression to calculate hazard ratio (HR) with 95% confidence intervals (CIs). Results For children and adolescents with ADHD (N = 9,421) the rate of any unintentional injuries (HR = 0.85; 95% CI = 0.78-0.92) and TBIs (HR = 0.27; 95% CIs = 0.20-0.38) during medicated periods was lower than during non-medicated periods. Similar results were found among individuals with co-occurring NDs (N = 2,986), for unintentional injuries (HR = 0.88; 95% CI = 0.77-1.01) and for TBIs (HR = 0.27; 95% CI = 0.16-0.44). Conclusions Beneficial effects of ADHD medication may extend beyond reduction of ADHD core symptoms to prevention of unintentional injuries in children and adolescents, including individuals with co-occurring NDs.
引用
收藏
页码:140 / 147
页数:8
相关论文
共 50 条
  • [31] Bipolar disorder and attention-deficit/hyperactivity disorder in children and adolescents
    Giedd, JN
    JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 : 31 - 34
  • [32] Attention-deficit/hyperactivity Disorder and Suicidality in Children and Adolescents
    Balazs, J.
    Miklosi, M.
    Kereszteny, A.
    Dallos, G.
    Gadoros, J.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [33] Managing Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    McClain, Elizabeth K.
    Burks, Erin Jewell
    PRIMARY CARE, 2015, 42 (01): : 99 - +
  • [34] ATTENTION-DEFICIT HYPERACTIVITY DISORDER - AIDS IN CHILDREN AND ADOLESCENTS
    ALGER, I
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1989, 40 (12): : 1222 - 1223
  • [35] Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Storebo, Ole J.
    Simonsen, Erik
    Gluud, Christian
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (18): : 2009 - 2010
  • [36] Attention-Deficit/Hyperactivity Disorder and Risk for Substance Use Disorders in Relatives
    Skoglund, Charlotte
    Chen, Qi
    Franck, Johan
    Lichtenstein, Paul
    Larsson, Henrik
    BIOLOGICAL PSYCHIATRY, 2015, 77 (10) : 880 - 886
  • [37] Clinical and functional characteristics of children and young adults with cerebral palsy and co-occurring attention-deficit/ hyperactivity disorder
    Casseus, Myriam
    Cheng, Jenfu
    Reichman, Nancy E.
    RESEARCH IN DEVELOPMENTAL DISABILITIES, 2024, 151
  • [38] Reduced Visual Evoked Potential Amplitude in Autistic Children with Co-Occurring Features of Attention-Deficit/Hyperactivity Disorder
    Cremone-Caira, Amanda
    Braverman, Yael
    MacNaughton, Gabrielle A. A.
    Nikolaeva, Julia I. I.
    Faja, Susan
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2024, 54 (08) : 2917 - 2925
  • [39] Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders
    Hah, M
    Chang, KK
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (06) : 996 - 1004
  • [40] Attention deficit hyperactivity disorder as a risk factor in unintentional poisonings and injuries
    Ruiz-Goikoetxea, Maite
    Cortese, Samuele
    Soutullo, Cesar
    Arrondo, Gonzalo
    ANALES DE PEDIATRIA, 2018, 88 (05): : 294 - 295